EDGAR Filing Documents for 0001567619-21-014403

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001567619-21-014403

Filing Date

2021-08-04

Accepted

2021-08-04 16:02:06

Documents

Period of Report

2021-08-02

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	doc1.html	4
1	FORM 4	doc1.xml	4	10942
	Complete submission text file	0001567619-21-014403.txt		14159

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116

Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40655 | Film No.: 211143904

Mailing Address C/O CORMORANT ASSET MANAGEMENT, LP 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116

Business Address

Type: 4 | Act: 34 | File No.: 001-40655 | Film No.: 211143903

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116

Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 617-848-3429

Cormorant Global Healthcare Master Fund, LP (Reporting) CIK: 0001618442 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40655 | Film No.: 211143902

Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102

Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (858) 775-4523

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116

Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0370

Cormorant Private Healthcare Fund III LP (Reporting) CIK: 0001817320 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40655 | Film No.: 211143901